1Cunningham D,Humblet Y,Siena S,et al.Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.N Engl J Med,2004,351:337-345.
2Xiong HQ,Rosenberg A,LoBugho A,et al.Cetuximab,a monoclonal antibody targeting the epidermal growth factor receptor,in combination with gemcitabine for advanced pancreatic cancer:a multicenter phase Ⅱ Trial.J Clin Oncol,2004,22:2610-2616.
3Saltz LB,Meropol NJ,Loehrer PJ Sr,et al.Phase Ⅱ trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.J Clin Oncol,2004,22:1201-1208.
